1Bergeron C,Amant F,Ferenczy A.Pathology and physiopathology of adenomyosis[J].Clin Obstet Gynae,2006,20(4):515-516.
2Ferrara N,Gerber HP,Le Couter J.The biology of VEGF and its receptors[J].Natmed,2003,9(16):669-676.
3Harfouche R,Hassessian HM,Guo Y,et al.Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells[J].Microvasc Res,2002,64:135-147.
7Yokomizo R,Matsuzaki S,Uehara S,et al.Expression of erythropoietin and erythropoietin receptor in peritoneal endometriosis[J].Mol Hum Reprod,2002,8(5):441-446.
8Whiteman SC,Bjanco A,Knight RA.Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 receptor to promote epithelial cell infectivity[J].Biol Chem,2003,278:11954.
6Kitawaki J, Obayashi H, Ishihara H, et al. Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata[ I ]. Hum Reprod,2001,16( 1 ) :51-55.
7Bischoff F, Simpson JL. Genetic basis of endometriosis [ J ]. Ann N Y Acad Sci,2004,1034:284-299.
8Davies EM,Sheffield DA,Tibarewal P,et al. The PTEN and Myo- tubularin phosphoinositide 3-phosphatases:linking lipid signalling to human disease [ J ]. Subcell Biochem,2012,58,281-336.
9Sonveaux P, Copetti T, De Saedeleer CJ et al. Targeting the lactate transporter MCTI in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis [ J ]. PLoS One, 2012, 7 (3) :e33418.
10Takei Y, Saga Y, Mizukami H, etal. Overexpression of PTEN in ovarian cancer cells suppresses i. p. dissemination and extends sur- vival in mice[ J]. Mal cancer Ther,2008,7 (3) :704-711.
